Ignite Creation Date:
2025-12-24 @ 12:38 PM
Ignite Modification Date:
2026-02-11 @ 10:44 AM
Study NCT ID:
NCT04500561
Status:
UNKNOWN
Last Update Posted:
2020-08-05
First Post:
2020-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial
Sponsor:
Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
YY-20394-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None